Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
LG Chem, Ltd. (051910.KS)
Seoul, KR
Established in Seoul, South Korea, in 1947, LG Chem, Ltd. is a global enterprise with diverse operations across petrochemicals, energy solutions, advanced materials, and life sciences. Its expansive reach covers South Korea, China, other Asian countries, the United States, Europe, and various international markets. Within its petrochemical segment, the company produces fundamental olefin products like ethylene, propylene, and butadiene, primarily sourced from naphtha. This division also yields an extensive array of synthetic resins and components, alongside aromatic petrochemicals such as benzene, polypropylene, bisphenol A, acrylonitrile butadiene styrene (ABS), engineered plastics (EP), polyvinyl chloride (PVC), plasticizers, acrylics, super absorbent polymers, and synthetic rubber. The energy solutions division specializes in manufacturing and supplying batteries for consumer electronics like mobile phones and laptops, electric vehicles, and large-scale energy storage systems. LG Chem's advanced materials business focuses on specialized products including polarizers, automotive components, glass substrates, OLED films and materials, and battery materials. It also provides reverse osmosis (RO) membranes, semiconductor materials, and display materials, such as LCD photoresists. In life sciences, the company's offerings include human growth hormones like Eutropin, diabetes treatments such as Zemiglo, bovine somatotropins (Boostin), vaccines, and hyaluronic acid dermal fillers (e.g., YVORIE). Additionally, they develop fine chemical products, exemplified by the PYANCHOR herbicide for rice farming. Beyond these core areas, LG Chem's activities encompass agricultural solutions, including crop protection products, seeds, fertilizers, and pesticides, alongside pharmaceutical research and facility management services. The company also manufactures and markets adhesives and electronic parts, distributes pharmaceutical products and water processing membranes, engages in agricultural pesticide licensing, and makes strategic investments in venture companies.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.96% | -11.19% | +5.90% | +12.04% | -4.19% | +16.90% | +79.10% | -45.20% | -56.32% | +30.90% | +2,800.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 7 | 0 |
| Buy | 12 | -2 |
| Hold | 6 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-6.1% Q1'26: +0.6% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-163.4% Q1'26: -626.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-2.4% Q1'26: -3.5% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-1.0% Q1'26: -0.4% (vs Q1'25)
-
ROIC Chemicals: +3.4%-0.7% Q1'26: -0.3% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.4% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×7.07× Q1'26: -170.08× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 11 Rev. Ana. 17 EPS Ana. |
Dec 2027 24 Rev. Ana. 14 EPS Ana. |
Dec 2028 11 Rev. Ana. 7 EPS Ana. |
Dec 2029 23 Rev. Ana. 8 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
20.21T
est: 20.32T (-0.6%)
|
20.66T
est: 20.55T (+0.5%)
|
25.70T
est: 25.74T (-0.2%)
|
28.18T
est: 27.90T (+1.0%)
|
28.63T
est: 29.04T (-1.4%)
|
30.08T
est: 30.00T (+0.2%)
|
42.65T
est: 42.86T (-0.5%)
|
50.98T
est: 53.07T (-3.9%)
|
55.25T
est: 56.60T (-2.4%)
|
48.92T
est: 49.20T (-0.6%)
|
45.93T
est: 45.86T (+0.1%)
|
51.36T
49.28T – 55.09T
+12.0% YoY
|
58.46T
46.82T – 70.57T
+13.8% YoY
|
64.28T
56.35T – 73.46T
+10.0% YoY
|
43.68T
38.30T – 49.92T
-32.0% YoY
|
| EBITDA |
3.08T
est: 2.70T (+14.0%)
|
3.33T
est: 2.73T (+21.8%)
|
4.07T
est: 3.42T (+18.9%)
|
3.56T
est: 3.71T (-3.9%)
|
2.55T
est: 3.86T (-34.0%)
|
3.41T
est: 3.99T (-14.5%)
|
7.95T
est: 5.70T (+39.4%)
|
6.47T
est: 7.06T (-8.3%)
|
7.09T
est: 7.53T (-5.8%)
|
5.37T
est: 6.45T (-16.8%)
|
4.78T
est: 6.01T (-20.5%)
|
6.73T
6.46T – 7.22T
+12.0% YoY
|
7.66T
6.14T – 9.25T
+13.8% YoY
|
8.43T
7.39T – 9.63T
+10.0% YoY
|
5.73T
5.02T – 6.54T
-32.0% YoY
|
| EBIT |
1.82T
est: 1.18T (+54.4%)
|
1.99T
est: 1.19T (+66.8%)
|
2.93T
est: 1.50T (+95.8%)
|
2.25T
est: 1.62T (+38.6%)
|
825.42B
est: 1.69T (-51.1%)
|
1.14T
est: 1.74T (-34.6%)
|
5.11T
est: 2.49T (+105.2%)
|
3.12T
est: 3.08T (+1.3%)
|
3.18T
est: 3.29T (-3.3%)
|
685.78B
est: 2.39T (-71.3%)
|
-465.91B
est: 2.22T (-120.9%)
|
2.49T
2.39T – 2.67T
+12.0% YoY
|
2.83T
2.27T – 3.42T
+13.8% YoY
|
3.12T
2.73T – 3.56T
+10.0% YoY
|
2.12T
1.86T – 2.42T
-32.0% YoY
|
| Net Income |
1.15T
est: 1.40T (-17.8%)
|
1.28T
est: 1.51T (-15.0%)
|
1.95T
est: 2.25T (-13.5%)
|
1.47T
est: 1.71T (-14.1%)
|
313.37B
est: 503.96B (-37.8%)
|
512.63B
est: 1.47T (-65.2%)
|
3.67T
est: 3.89T (-5.8%)
|
1.85T
est: 2.42T (-23.7%)
|
1.34T
est: 1.82T (-26.4%)
|
-690.85B
est: 430.04B (-260.6%)
|
-1.82T
est: -124.62B (-1,360.0%)
|
208.48B
-678.74B – 1.54T
+267.3% YoY
|
1.87T
797.94B – 3.09T
+795.1% YoY
|
3.08T
2.58T – 3.65T
+64.9% YoY
|
6.97T
5.85T – 8.26T
+126.4% YoY
|
| SGA |
1.05T
est: 1.71T (-38.4%)
|
1.14T
est: 1.73T (-34.1%)
|
1.41T
est: 2.16T (-34.8%)
|
1.68T
est: 2.35T (-28.4%)
|
2.30T
est: 2.44T (-5.8%)
|
2.76T
est: 2.52T (+9.2%)
|
3.96T
est: 3.61T (+10.0%)
|
4.07T
est: 4.46T (-8.9%)
|
3.63T
est: 4.76T (-23.8%)
|
4.43T
est: 4.14T (+6.9%)
|
4.24T
est: 3.86T (+9.6%)
|
4.33T
4.15T – 4.64T
+12.0% YoY
|
4.92T
3.94T – 5.94T
+13.8% YoY
|
5.42T
4.75T – 6.19T
+10.0% YoY
|
3.68T
3.23T – 4.21T
-32.0% YoY
|
| EPS |
15,674.00
est: 17,928.22 (-12.6%)
|
17,417.00
est: 19,249.36 (-9.5%)
|
25,367.00
est: 28,717.81 (-11.7%)
|
19,217.00
est: 21,907.95 (-12.3%)
|
4,090.27
est: 6,438.30 (-36.5%)
|
6,670.62
est: 18,842.16 (-64.6%)
|
47,113.00
est: 49,751.69 (-5.3%)
|
23,675.00
est: 30,916.30 (-23.4%)
|
17,086.00
est: 23,234.69 (-26.5%)
|
-8,826.00
est: 5,474.79 (-261.2%)
|
-23,244.00
est: -1,586.55 (-1,365.1%)
|
2,654.18
-8,641.03 – 19,594.82
+267.3% YoY
|
23,757.09
10,158.46 – 39,279.62
+795.1% YoY
|
39,167.38
32,888.18 – 46,435.84
+64.9% YoY
|
88,691.88
74,473.05 – 105,150.82
+126.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-15 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Cheol-Ho Yang | VP & Head of Petrochemical Management Strategy Group | — | male |
| Dong Seok Cha | Executive Vice President, Internal Accounting Manager, Chief Financial Officer & Director | — | male |
| Dong-Choon Kim | President, CEO & Director | — | male |
| Hyun-suk Yoon | Head of Investor Relations Division | — | — |
| Ji-yung Yu | CTO & Chief Sustainability Officer | — | male |
| Seung-se Chang | Senior Vice President | — | — |
| Su-hee Yoon | Senior Vice President | — | female |
| Young-Suk Lee | Vice President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 051910.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
